Proteomics International Laboratories Limited
ASX: PIQ
PromarkerD launches and US reimbursement wins position Proteomics International for accelerated commercial growth.
(Source: TradingView) 3-Month Performance Profile of PIQ on a DTF compared to S&P/ASX 200 (XJO).
Proteomics International Laboratories closed FY25 with cash reserves of $11.04 million. The year marked a major milestone with
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
